{"product_id":"ipamorelin","title":"Ipamorelin","description":"\u003ch2\u003eAbout Ipamorelin\u003c\/h2\u003e\n\u003cp\u003eIpamorelin is a synthetic pentapeptide with the molecular formula C\u003csub\u003e38\u003c\/sub\u003eH\u003csub\u003e49\u003c\/sub\u003eN\u003csub\u003e9\u003c\/sub\u003eO\u003csub\u003e5\u003c\/sub\u003e and a molecular weight of 711.9 g\/mol, assembled from the residue sequence Aib His D-2-Nal D-Phe Lys NH2. Peptsche supplies it as a lyophilized powder sealed in a single use glass vial, a form that keeps the peptide stable through transport and cold storage. In the published literature ipamorelin has been studied in connection with ghrelin receptor pharmacology, growth hormone secretagogue selectivity, pituitary cell signalling and skeletal endpoints in rodent models. Peptsche supplies Ipamorelin strictly as a research material for controlled laboratory investigation.\u003c\/p\u003e\n\n\u003ch3\u003eAvailable Sizes\u003c\/h3\u003e\n\u003cp\u003eThis listing covers one vial configuration. Every lot is assayed before release, so the stated purity applies to the batch shipped.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e5mg vial of lyophilized Ipamorelin, 99% or greater purity by HPLC\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eProduct Specifications\u003c\/h3\u003e\n\u003ctable\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eProduct\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIpamorelin\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eApplication\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eResearch use only. Laboratory and in vitro investigation.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAppearance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eWhite to off white lyophilized powder\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eChemical Formula\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eC\u003csub\u003e38\u003c\/sub\u003eH\u003csub\u003e49\u003c\/sub\u003eN\u003csub\u003e9\u003c\/sub\u003eO\u003csub\u003e5\u003c\/sub\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMolecular Weight\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e711.9 g\/mol\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCAS Number\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e170851-70-4\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePubChem CID\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/9831659\" target=\"_blank\" rel=\"noopener\"\u003e9831659\u003c\/a\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSequence\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAib His D-2-Nal D-Phe Lys NH2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSynonyms\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eNNC 26-0161, ipamorelin acetate\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePurity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e99% or greater by HPLC, verified per batch\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStorage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStore sealed at 2 to 8 °C, protected from heat, light and moisture\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRegulatory Status\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eResearch use compound. Not approved for human or veterinary use in any jurisdiction. Placed in Category 2 of the United States Food and Drug Administration list of bulk drug substances that may present significant safety risks.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\u003c\/table\u003e\n\n\u003ch2\u003eWhat is Ipamorelin?\u003c\/h2\u003e\n\u003cp\u003eChemically, ipamorelin is a short synthetic peptide of five residues carrying an amidated carboxy terminus. Two of its building blocks are not standard proteinogenic amino acids: alpha aminoisobutyric acid, abbreviated Aib, and the D configured naphthylalanine residue D-2-Nal. With the D configured phenylalanine, these substitutions give the molecule a constrained conformation and greater resistance to enzymatic breakdown in the assay conditions used.\u003c\/p\u003e\n\u003cp\u003eThe compound was developed in the 1990s and carries the laboratory code NNC 26-0161. Raun and colleagues described it in 1998 as the first selective growth hormone secretagogue, a characterisation based on comparisons with earlier peptides in the same class. Follow up rodent work by Johansen and by Svensson examined skeletal endpoints, and those three papers form the core of the primary literature.\u003c\/p\u003e\n\u003cp\u003eThe evidence base for ipamorelin is preclinical. Published findings come from receptor assays, isolated pituitary cell preparations and rodent studies, and they describe what was observed in those defined systems. Ipamorelin is not approved for human or veterinary use in any jurisdiction and appears in Category 2 of the Food and Drug Administration list of bulk drug substances that may present significant safety risks.\u003c\/p\u003e\n\n\u003ch2\u003eIpamorelin Mechanism of Action (Research Only)\u003c\/h2\u003e\n\u003cp\u003eMechanistic accounts centre on interaction with a single receptor and on the selectivity that follows from the compact structure. The summaries below describe reported preclinical observations, not effects in humans.\u003c\/p\u003e\n\n\u003ch3\u003eGhrelin Receptor GHS-R1a Agonism\u003c\/h3\u003e\n\u003cp\u003eIpamorelin is characterised in the literature as an agonist at the growth hormone secretagogue receptor GHS-R1a, the same receptor engaged by the endogenous peptide ghrelin. In receptor assays and isolated pituitary preparations, investigators reported engagement and downstream signalling consistent with that classification, and antagonist studies were used to confirm that the responses depend on the receptor.\u003c\/p\u003e\n\n\u003ch3\u003eSecretagogue Selectivity Relative to Earlier Peptides\u003c\/h3\u003e\n\u003cp\u003eThe point emphasised by Raun and colleagues is selectivity. In the comparisons reported in that work, ipamorelin produced growth hormone release in the models used without the parallel changes in other pituitary and adrenal hormones seen with earlier compounds in the class. Later work, including Svensson's comparison against GHRP-6, used the two peptides as contrasting probes of the same receptor system.\u003c\/p\u003e\n\n\u003ch3\u003ePentapeptide Structure and Receptor Binding\u003c\/h3\u003e\n\u003cp\u003eStructure activity work relates the observed selectivity to the compact pentapeptide scaffold. The Aib residue restricts backbone flexibility, the D configured aromatic residues occupy a hydrophobic pocket described in binding models, and the amidated terminus removes a charged group. Together these features are described as producing a defined binding mode.\u003c\/p\u003e\n\n\u003ch3\u003eIntegrated Mechanistic Profile\u003c\/h3\u003e\n\u003cp\u003eThe preclinical literature describes ipamorelin through three connected themes.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eSingle receptor engagement.\u003c\/strong\u003e Agonism at GHS-R1a reported in receptor assays and isolated pituitary preparations.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSelectivity.\u003c\/strong\u003e Growth hormone release in the models used without the broader hormonal changes reported for earlier secretagogues.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStructural constraint.\u003c\/strong\u003e Non standard residues that restrict conformation and define the binding mode in the systems tested.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eNote:\u003c\/strong\u003e Ipamorelin is supplied strictly for research use only. It is intended as an experimental compound for qualified laboratory personnel and is not a drug, food or cosmetic.\u003c\/p\u003e\n\u003cp\u003eIpamorelin is supplied exclusively for laboratory research use and is not intended for human or veterinary application.\u003c\/p\u003e\n\n\u003ch2\u003eResearch Applications (Observations from Studies)\u003c\/h2\u003e\n\u003cp\u003eThe areas below describe how ipamorelin has been used as a research tool and what was reported.\u003c\/p\u003e\n\n\u003ch3\u003ePituitary Cell and Receptor Assay Systems\u003c\/h3\u003e\n\u003cp\u003eIsolated pituitary cell preparations and cells expressing the cloned receptor are the standard systems for this compound. Reported endpoints include receptor binding measurements, second messenger readouts and hormone concentrations in culture medium. Because it is described as selective, it is often used to isolate one arm of a signalling system that other probes engage more broadly.\u003c\/p\u003e\n\n\u003ch3\u003eSkeletal Endpoints in Rodent Models\u003c\/h3\u003e\n\u003cp\u003eJohansen and colleagues examined longitudinal bone growth in rats, and Svensson and colleagues measured bone mineral content in adult female rats alongside GHRP-6. In the animal models used, investigators reported measurable differences in the skeletal parameters recorded. Those findings are specific to the species and conditions described in each paper.\u003c\/p\u003e\n\n\u003ch3\u003eComparative Secretagogue Pharmacology\u003c\/h3\u003e\n\u003cp\u003eIpamorelin appears frequently as a reference compound when newer molecules at the same receptor are characterised. In that role it provides a comparison point for binding affinity, selectivity profiling and assay validation.\u003c\/p\u003e\n\n\u003cp\u003eIpamorelin is supplied exclusively for laboratory research use and is not intended for human or veterinary application.\u003c\/p\u003e\n\u003ch2\u003eIpamorelin Compared With Related Research Compounds\u003c\/h2\u003e\n\u003cp\u003eThe table below places Ipamorelin alongside two related compounds in the Peptsche range. It is offered to clarify differences in classification, molecular target and research context. It should not be read as a comparison of clinical performance, safety, or suitability for any application.\u003c\/p\u003e\n\u003ctable\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCharacteristic\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eIpamorelin\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e\u003ca href=\"\/products\/cjc-1295\"\u003eCJC-1295\u003c\/a\u003e\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e\u003ca href=\"\/products\/sermorelin\"\u003eSermorelin\u003c\/a\u003e\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eResearch Classification\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSynthetic pentapeptide growth hormone secretagogue\u003c\/td\u003e\n\u003ctd\u003eSynthetic 29 residue analogue of growth hormone releasing factor\u003c\/td\u003e\n\u003ctd\u003eSynthetic 29 residue fragment of human growth hormone releasing hormone\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePrimary Molecular Target\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eGhrelin receptor GHS-R1a on pituitary somatotrophs\u003c\/td\u003e\n\u003ctd\u003eGrowth hormone releasing factor receptor on pituitary somatotrophs\u003c\/td\u003e\n\u003ctd\u003eGrowth hormone releasing hormone receptor on pituitary somatotrophs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMechanistic Profile\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAgonism at the ghrelin receptor GHS-R1a, a receptor system separate from the growth hormone releasing hormone receptor\u003c\/td\u003e\n\u003ctd\u003eAgonism at the growth hormone releasing hormone receptor, with a brief plasma profile\u003c\/td\u003e\n\u003ctd\u003eAgonism at the growth hormone releasing hormone receptor, unmodified parent scaffold\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePrimary Research Focus\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003ePituitary cell and receptor assays, rodent skeletal endpoints, comparative secretagogue pharmacology\u003c\/td\u003e\n\u003ctd\u003eReceptor pharmacology, comparative stability and analytical method development\u003c\/td\u003e\n\u003ctd\u003eReference comparator in analogue design, peptide modification chemistry, endocrine signalling models\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStructural Design\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eFive residues including non standard Aib and D configured aromatic residues, amidated terminus\u003c\/td\u003e\n\u003ctd\u003e29 residues with four substitutions, no albumin binding moiety\u003c\/td\u003e\n\u003ctd\u003eResidues 1 to 29 with a terminal amide, one methionine, no unnatural residues\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRegulatory Status\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eResearch use compound, not approved for human or veterinary use in any jurisdiction, and placed in Category 2 of the United States Food and Drug Administration list of bulk drug substances\u003c\/td\u003e\n\u003ctd\u003eResearch use compound, not approved for human or veterinary use in any jurisdiction, and withdrawn from consideration on the United States Food and Drug Administration bulk drug substances list\u003c\/td\u003e\n\u003ctd\u003eFormerly the active ingredient in an approved medicine marketed as Geref by EMD Serono, with all products under those applications now discontinued. Material supplied is research grade, is not that former medicine, and is not approved for human or veterinary use\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\u003c\/table\u003e\n\u003cp\u003eIpamorelin is supplied exclusively for laboratory research use and is not intended for human or veterinary application.\u003c\/p\u003e\n\u003ch2\u003eLaboratory Handling and Storage Considerations\u003c\/h2\u003e\n\u003cp\u003eLyophilized ipamorelin should be stored sealed at 2 to 8 °C, protected from heat, light and moisture. The powder is hygroscopic, so vials should reach ambient temperature before opening. Peptides of this class are sensitive to extremes of pH and to prolonged storage in solution, so prepared solutions should be aliquoted rather than cycled repeatedly through freezing and thawing, and each container should carry compound identity, lot number and preparation date.\u003c\/p\u003e\n\n\u003ch3\u003eLaboratory Safety Considerations\u003c\/h3\u003e\n\u003cp\u003eThe practices below apply to routine handling in a research setting.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePersonal protective equipment:\u003c\/strong\u003e Wear nitrile gloves, a laboratory coat and side shield safety glasses whenever a vial is open.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEngineering controls:\u003c\/strong\u003e Weigh and prepare solutions in a certified fume hood to limit dispersal of the fine powder.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExposure prevention:\u003c\/strong\u003e Avoid skin, eye and mucous membrane contact, keep food out of the working area and wash hands afterwards.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Keep sealed vials at 2 to 8 °C in a dedicated research chemical location, separated from consumer products.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSpill response:\u003c\/strong\u003e Collect spilled powder without raising dust, decontaminate the surface and treat the residue as chemical waste.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDisposal:\u003c\/strong\u003e Discard unused material, solutions and contaminated consumables through the institutional chemical waste stream.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDocumentation:\u003c\/strong\u003e Record lot number, receipt date, storage conditions and each preparation so that results stay traceable to a batch.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCertificate of Analysis and Quality Assurance\u003c\/h2\u003e\n\u003cp\u003eEvery production lot of Ipamorelin supplied by Peptsche undergoes analytical evaluation, and a batch specific Certificate of Analysis accompanies each order to support research documentation, quality control and experimental consistency.\u003c\/p\u003e\n\u003cp\u003eEach Certificate of Analysis typically includes:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eIdentity verification\u003c\/strong\u003e using analytical techniques such as mass spectrometry to confirm the molecular characteristics of the material supplied.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity analysis\u003c\/strong\u003e performed by high performance liquid chromatography to quantify purity and identify potential impurities.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBatch documentation\u003c\/strong\u003e recording lot number, testing date, analytical methods applied and quality assessment results.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTraceability information\u003c\/strong\u003e to support laboratory recordkeeping and reproducibility across research workflows.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003ePeptsche works with Janoshik Analytical, an independent testing laboratory, for third party verification of research material quality. Independent testing provides transparency and confidence in product identity, consistency and sourcing, and batch specific documentation can be retained as part of laboratory records and internal quality procedures.\u003c\/p\u003e\n\u003cp\u003eIpamorelin is supplied exclusively for laboratory research use and is not intended for human or veterinary application.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003ch3\u003eWhat is Ipamorelin?\u003c\/h3\u003e\n\u003cp\u003eIpamorelin is a synthetic pentapeptide assembled from the residue sequence Aib His D-2-Nal D-Phe Lys NH2, with a molecular weight of 711.9 g\/mol. Two of its building blocks are not standard proteinogenic amino acids, which gives the molecule a constrained conformation and greater resistance to enzymatic breakdown. Peptsche supplies it as a lyophilized powder sealed in a single use glass vial.\u003c\/p\u003e\n\u003ch3\u003eWhat is Ipamorelin studied for in research?\u003c\/h3\u003e\n\u003cp\u003ePublished investigation is preclinical and spans ghrelin receptor pharmacology, growth hormone secretagogue selectivity, pituitary cell signalling and skeletal endpoints in rodent models. Ipamorelin also appears frequently as a reference compound when newer molecules at the same receptor are characterised. Those findings are specific to the species and conditions described in each paper.\u003c\/p\u003e\n\u003ch3\u003eHow does Ipamorelin work in laboratory research?\u003c\/h3\u003e\n\u003cp\u003eThe literature characterises ipamorelin as an agonist at the growth hormone secretagogue receptor GHS-R1a, the same receptor engaged by the endogenous peptide ghrelin. Antagonist studies were used to confirm that the reported responses depend on that receptor. The compact pentapeptide scaffold and its non standard residues are described as producing a defined binding mode.\u003c\/p\u003e\n\u003ch3\u003eHow is the quality of Peptsche Ipamorelin verified?\u003c\/h3\u003e\n\u003cp\u003eEvery production lot of Peptsche Ipamorelin is evaluated analytically, with identity confirmed using techniques such as mass spectrometry and purity quantified by high performance liquid chromatography. Peptsche works with Janoshik Analytical, an independent testing laboratory, for third party verification, and a batch specific Certificate of Analysis accompanies each order.\u003c\/p\u003e\n\u003ch3\u003eHow should unopened Ipamorelin be stored?\u003c\/h3\u003e\n\u003cp\u003eUnopened vials should be stored sealed at 2 to 8 °C, protected from heat, light and moisture. Vials should reach ambient temperature before opening so condensation does not form on the cold powder. Lot number, receipt date and storage conditions should be recorded in laboratory documentation so results stay traceable to a batch.\u003c\/p\u003e\n\u003ch3\u003eIs Ipamorelin intended for human use?\u003c\/h3\u003e\n\u003cp\u003eNo. Ipamorelin is supplied strictly for laboratory research use only. It is not approved for human consumption, veterinary use, diagnosis, treatment or any medical application.\u003c\/p\u003e\n\u003ch3\u003eWhy do researchers choose Peptsche for Ipamorelin?\u003c\/h3\u003e\n\u003cp\u003ePeptsche supplies Ipamorelin at 99% or greater purity by HPLC, verified per batch, sealed in a single use glass vial. Every lot is assayed before release, so the stated purity applies to the batch shipped, and independent third party verification with full lot traceability supports reproducibility across research workflows.\u003c\/p\u003e\n\n\u003ch2\u003eScientific References\u003c\/h2\u003e\n\u003col\u003e\n\u003cli\u003eRaun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH. Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology. 1998;139(5):552 to 561. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9849822\/\" target=\"_blank\" rel=\"noopener\"\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/9849822\/\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eJohansen PB, Nowak J, Skjaerbaek C, Flyvbjerg A, Andreassen TT, Wilken M, Orskov H. Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats. Growth Hormone and IGF Research. 1999;9(2):106 to 113. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10373343\/\" target=\"_blank\" rel=\"noopener\"\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/10373343\/\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eSvensson J, Lall S, Dickson SL, Bengtsson BA, Rømer J, Ahnfelt-Rønne I, Ohlsson C, Jansson JO. The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats. Journal of Endocrinology. 2000;165(3):569 to 577. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10828840\/\" target=\"_blank\" rel=\"noopener\"\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/10828840\/\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2\u003eRESEARCH USE ONLY\u003c\/h2\u003e\n\u003cp\u003eThese compounds are NOT intended for human consumption, clinical use, or veterinary applications. We are not affiliated with any pharmaceutical companies or their commercial medications. By placing an order, you certify these materials will be used exclusively for in vitro testing and laboratory experimentation only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.\u003c\/p\u003e","brand":"Peptsche","offers":[{"title":"5mg","offer_id":43752773943359,"sku":"PEP-IPA-5MG","price":35.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0675\/7394\/0287\/files\/peptsche_Ipamorelin_5mg.png?v=1786902688","url":"https:\/\/peptsche.com\/products\/ipamorelin","provider":"Peptsche","version":"1.0","type":"link"}